Your browser doesn't support javascript.
loading
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies.
Mesa, Ruben A; Kiladjian, Jean-Jacques; Verstovsek, Srdan; Al-Ali, Haifa Kathrin; Gotlib, Jason; Gisslinger, Heinz; Levy, Richard; Siulnik, Andres; Gupta, Vikas; Khan, Mahmudul; DiPersio, John F; McQuitty, Mari; Catalano, John V; Hunter, Deborah S; Knoops, Laurent; Deininger, Michael; Cervantes, Francisco; Miller, Carole; Vannucchi, Alessandro M; Silver, Richard T; Barbui, Tiziano; Talpaz, Moshe; Barosi, Giovanni; Winton, Elliott F; Mendeson, Estella; Harvey, Jimmie H; Arcasoy, Murat O; Hexner, Elizabeth; Lyons, Roger M; Paquette, Ronald; Raza, Azra; Sun, William; Sandor, Victor; Kantarjian, Hagop M; Harrison, Claire.
Affiliation
  • Mesa RA; claire.harrison@gstt.nhs.uk.
Haematologica ; 99(2): 292-8, 2014 Feb.
Article in En | MEDLINE | ID: mdl-23911705
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Quality of Life / Spleen / Protein Kinase Inhibitors Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2014 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Quality of Life / Spleen / Protein Kinase Inhibitors Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2014 Type: Article